Baxter International Inc. (BAX)

NYSE · Medical Instruments & Supplies

25.70
+0.22 (+0.86%)
Updated Sep 3, 1:54 AM ET
AI Rating
Buy
Overall Score
68
Trend
100
Momentum
35
Risk
63

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Aug 20, 2025 260 sessions Sep 1, 2026

AI Analysis

Baxter International Inc. is trading at $25.70, up 0.86% on the session. The 50 day average sits at $24.43 and the 200 day at $20.23, which puts the stock in a uptrend. RSI is at 47.6, which reads as neutral, and MACD is bearish crossover. Volume is below average.

The nearest support is around $21.40 with resistance near $26.76, so that band frames the current range. Average daily movement is roughly $0.86, or about 3.3% of the share price, which is what any stop placement has to allow for. The overall health score of 68 out of 100 combines a trend score of 100, momentum of 35 and a risk score of 63.

Technical indicators

RSI (14)
47.6
neutral
MACD
0.368
bearish crossover
SMA 20
26.60
SMA 50
24.43
SMA 200
20.23
uptrend
ATR (14)
0.86
avg daily range
Support
21.40
Resistance
26.76
Volume vs 20d
0.87x
below average
Volatility
25.8%
annualised
1 month
-9.32%
3 months
+36.40%

About Baxter International Inc.

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.